bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board
The caliber of the physicians and researchers who accepted our invitation to join our Scientific and Medical Advisory Board will accelerate the work of our own scientists to bring breakthrough technology to the early diagnosis of cancer.
- The caliber of the physicians and researchers who accepted our invitation to join our Scientific and Medical Advisory Board will accelerate the work of our own scientists to bring breakthrough technology to the early diagnosis of cancer.
- Habib and Hill join Science and Medical Advisory Board members Neil Alexis, PhD, Catherine Sears, MD, and Gerard Silvestri, MD.
- Gerard Silvestri , MD, MS, FCCP, Professor of Medicine and Lung Cancer Pulmonologist at the Medical University of South Carolina.
- Research and optimization of the Companys platform technologies are conducted in its laboratories at The University of Texas at San Antonio.